Boston musings.
P2B or P3 may be the burning question.
Pathways??
I wonder if the new HIV/225 patents will be part of a change of tack, with regard to the parameters of the next trial. Will they pursue eradication or will they pursue to prove the human value of the immune response over a longer period.
Is a treatment interruption trial, as mentioned previously by MM in an interview, no longer a pipedream here?
Will they take aim at both?
How?
- Forums
- ASX - By Stock
- The Boston CROI connection
Boston musings. P2B or P3 may be the burning question....
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.97M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.1¢ | $15.54K | 496.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 856074 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 153416 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 856074 | 0.030 |
5 | 1152888 | 0.029 |
4 | 468000 | 0.028 |
2 | 137000 | 0.027 |
4 | 3254559 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 153416 | 1 |
0.032 | 149999 | 2 |
0.033 | 135200 | 3 |
0.034 | 100000 | 1 |
0.035 | 299251 | 4 |
Last trade - 11.52am 31/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online